| 标题 |
Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Pier Luigi Zinzani; Felipe Samaniego; Wojciech Jurczak; Nilanjan Ghosh; Enrico Derenzini; et al 出版日期:2020-11-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)